No evidence Tamiflu caused deaths: FDA

U.S. regulators so far have found no evidence Roche AG’s antiflu drug Tamiflu caused the deaths of children in Japan, a U.S. Food and Drug Administration spokeswoman said on Friday.

The FDA has been studying reports of the deaths of 12 children in Japan as well as other cases of possible side effects in children who had taken Roche’s flu-fighting drug, which is in high demand as a defense against a possible avian flu pandemic in people.

FDA officials are seeking input about the reports from a panel of outside experts that is meeting Friday. The agency plans to ask the committee whether regulators should update warnings on Tamiflu or continue to monitor the drug’s safety.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   UGA ecologist finds another cause of antibiotic resistance   New drug for neuroblastoma shows promise in phase I study   Baclofen shows promise in patients with alcohol-induced liver disease   Findings point to an ‘off switch’ for drug resistance in cancer   Stopping statins may benefit terminally ill patients   Cholesterol drug users may use pills as a license to overeat   Pfizer lung cancer drug beats chemo for previously untreated patients   Mass. General study identifies path to safer drugs for heart disease, cancer   Gates Foundation awards Notre Dame $23 million for malaria, dengue studies   Cancer drug protects against diabetes   Malaria drug target raises hopes for new treatments